Disclosed are mGluR4 positive allosteric modulator ligands of general formula (I) and radiolabeled derivates, their use as therapeutic agents for the treatment of central nervous system disorders modulated by mGluR4 and as ligands for the labeling and diagnostic imaging of mGluR4 in mammals.
本发明揭示了通式(I)的mGluR4阳性变构调节剂
配体和放射性标记衍
生物,它们可作为治疗中枢神经系统疾病的治疗剂,这些疾病受mGluR4调节,同时也可作为哺乳动物体内mGluR4的标记和诊断成像的
配体。